Pediatric Eye Disorders Clinical Trials
David Coats, M.D.
or call 832-822-3230
Three-month, double-masked, active treatment controlled, multicenter study of two percent Dorzolamide T.I.D. and of Timolol Maleate in gel-forming solution Q.D. in pediatric patients age less than six years with intraocular pressure or glaucoma.